Remove ads

Introducing the LemonFools Personal Finance Calculators

GlaxoSmithKline PLC (GSK)

Share latest information on individual companies and hot news discussions. FTSE 350 companies only
Forum rules
No penny shares or promotional posts
idpickering
Lemon Quarter
Posts: 3920
Joined: November 4th, 2016, 5:04 pm
Has thanked: 560 times
Been thanked: 1151 times

GlaxoSmithKline PLC (GSK)

#195174

Postby idpickering » January 21st, 2019, 7:05 am

GlaxoSmithKline plc (LSE/NYSE: GSK) today announces that Sir Philip Hampton has informed the Board of his intention to step down as non-executive Chairman and the Board has started the process to find a successor.


https://www.investegate.co.uk/glaxosmit ... 00466088N/

maximan
2 Lemon pips
Posts: 141
Joined: November 4th, 2016, 3:41 pm
Has thanked: 154 times
Been thanked: 44 times

GSK Completes Acquisition of Tesaro

#195579

Postby maximan » January 22nd, 2019, 2:02 pm

https://www.londonstockexchange.com/exc ... K/13943004.

RNS Number : 7937N
GlaxoSmithKline PLC
22 January 2019




Issued: 22 January 2019, London UK - LSE Announcement



GSK completes acquisition of TESARO, an oncology focused biopharmaceutical company





GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that it has successfully completed the acquisition of TESARO, Inc. an oncology-focused company based in Waltham, Massachusetts, for an aggregate cash consideration of approximately $5.1 billion (£4.0 billion). The transaction, which was announced on 3 December 2018, significantly strengthens GSK's pharmaceutical business, accelerating the build of GSK's pipeline and commercial capability in oncology.[url][url][/url][/url]

maximan
2 Lemon pips
Posts: 141
Joined: November 4th, 2016, 3:41 pm
Has thanked: 154 times
Been thanked: 44 times

GlaxoSmithKline Plc (GSK)

#199056

Postby maximan » February 5th, 2019, 1:14 pm

GSK and Merck KGaA, Darmstadt, Germany announce global alliance to jointly develop and commercialise M7824, a novel immunotherapy with potential in multiple difficult-to-treat cancers
https://www.investegate.co.uk/glaxosmit ... 58321388P/

moorfield
Lemon Quarter
Posts: 1416
Joined: November 7th, 2016, 1:56 pm
Has thanked: 286 times
Been thanked: 317 times

Re: RNS GSK and Merck global alliance

#199068

Postby moorfield » February 5th, 2019, 2:22 pm

More temporary good news for big pharma shareholders.

I wonder how this will work in 52 days time. :o :twisted:

Raptor
Lemon Quarter
Posts: 1651
Joined: November 4th, 2016, 1:39 pm
Has thanked: 148 times
Been thanked: 307 times

Re: GlaxoSmithKline Plc (GSK)

#201878

Postby Raptor » February 17th, 2019, 9:27 am


idpickering
Lemon Quarter
Posts: 3920
Joined: November 4th, 2016, 5:04 pm
Has thanked: 560 times
Been thanked: 1151 times

Re: GlaxoSmithKline Plc (GSK)

#203165

Postby idpickering » February 22nd, 2019, 12:05 pm

GSK response to SFO Statement

In reference to the announcement issued by the Serious Fraud Office ("SFO") today, GlaxoSmithKline plc (LSE/NYSE: GSK) is pleased that the SFO have closed their investigation and concluded that no further action is required.


https://www.investegate.co.uk/glaxosmit ... 21488883Q/

idpickering
Lemon Quarter
Posts: 3920
Joined: November 4th, 2016, 5:04 pm
Has thanked: 560 times
Been thanked: 1151 times

Re: GlaxoSmithKline PLC (GSK)

#206368

Postby idpickering » March 8th, 2019, 7:06 am

ViiV positive ph3 data for long acting injectable

ViiV Healthcare presents positive, 48-week data from two pivotal phase III studies showing long-acting, injectable two-drug regimen of cabotegravir and rilpivirine has similar efficacy to daily, three-drug oral treatment in adults living with HIV-1 infection


https://www.investegate.co.uk/glaxosmit ... 00022408S/

idpickering
Lemon Quarter
Posts: 3920
Joined: November 4th, 2016, 5:04 pm
Has thanked: 560 times
Been thanked: 1151 times

Re: GlaxoSmithKline PLC (GSK)

#207669

Postby idpickering » March 14th, 2019, 1:28 pm

Is the GSK share price the bargain of the year?

FTSE 100 pharma giant GlaxoSmithKline (LSE: GSK) is heading for a break-up. Chief executive Emma Walmsley will oversee the creation of two companies — a focused and faster-growing pharmaceutical company and a profitable, stable consumer healthcare business.

This strategy isn’t a sure thing, but I think there’s a good chance it will work. Today I’ll explain why. I’ll also take a look a FTSE 250 stock which I think offers an interesting mix of opportunity and risk.

A break-up makes sense


https://www.fool.co.uk/investing/2019/0 ... -the-year/

maximan
2 Lemon pips
Posts: 141
Joined: November 4th, 2016, 3:41 pm
Has thanked: 154 times
Been thanked: 44 times

Glaxo Smith Kline (GSK)

#208706

Postby maximan » March 19th, 2019, 5:50 pm

RNS Number : 3623T
GlaxoSmithKline PLC
19 March 2019




Issued: 19 March 2019, London UK - LSE Announcement



Data from GARNET study indicates robust activity of dostarlimab in patients with advanced or recurrent endometrial cancer



· GARNET is the single largest study to date of an anti-PD-1 monotherapy in women with advanced or recurrent MSI-H and MSS endometrial cancer

· Results demonstrate clinically meaningful and durable response rates of dostarlimab monotherapy, in MSI-H and MSS tumours

· BLA submission planned for dostarlimab in endometrial cancer at the end of 2019
https://www.investegate.co.uk/glaxosmit ... mab/201903

maximan
2 Lemon pips
Posts: 141
Joined: November 4th, 2016, 3:41 pm
Has thanked: 154 times
Been thanked: 44 times

Re: Glaxo Smith Kline (GSK)

#208709

Postby maximan » March 19th, 2019, 6:01 pm

Sorry link keeps failing. It is on Investigate if you go direct.

Itsallaguess
Lemon Quarter
Posts: 3204
Joined: November 4th, 2016, 1:16 pm
Has thanked: 969 times
Been thanked: 1945 times

Re: Glaxo Smith Kline (GSK)

#208711

Postby Itsallaguess » March 19th, 2019, 6:10 pm

maximan wrote:
Sorry link keeps failing. It is on Investigate if you go direct.


This one should work -

https://www.investegate.co.uk/glaxosmit ... 45023623T/

Cheers,

Itsallaguess

maximan
2 Lemon pips
Posts: 141
Joined: November 4th, 2016, 3:41 pm
Has thanked: 154 times
Been thanked: 44 times

Re: GlaxoSmithKline PLC (GSK)

#209173

Postby maximan » March 21st, 2019, 4:47 pm

GlaxoSmithKline plc (LSE/NYSE: GSK) today announced further positive data from the DREAMM-1 study of patients with relapsed/refractory multiple myeloma who received GSK2857916, an investigational anti-B-cell maturation antigen (BCMA) antibody-drug conjugate. These results, published in Blood Cancer Journal (link) build upon results from the pre-specified interim analysis, which were first presented at the American Society of Haematology Congress in 2017.

https://www.investegate.co.uk/glaxosmit ... 00016374T/

idpickering
Lemon Quarter
Posts: 3920
Joined: November 4th, 2016, 5:04 pm
Has thanked: 560 times
Been thanked: 1151 times

Re: GlaxoSmithKline PLC (GSK)

#213783

Postby idpickering » April 9th, 2019, 7:05 am

FDA approves ViiV's two-drug HIV regimen, Dovato

ViiV Healthcare today announced that the US Food and Drug Administration (FDA) approved Dovato, a complete, once-daily, single-tablet regimen of dolutegravir (DTG) 50 mg and lamivudine (3TC) 300 mg for the treatment of HIV-1 infection in adults with no antiretroviral (ARV) treatment history and with no known resistance to either DTG or 3TC. Dovato, a two-drug regimen (2DR), reduces exposure to the number of ARVs from the start of treatment, while still maintaining the efficacy and high barrier to resistance of a traditional DTG-based three-drug regimen.1


https://www.investegate.co.uk/glaxosmit ... 00025072V/


Return to “Company Share news (FTSE 350)”

Who is online

Users browsing this forum: monabri and 0 guests